In this JMP Statistically Speaking Webinar, Dr. Loren Perelman will discuss how you can enable a stronger analytical culture in your R&D Organization.
Riffyn's first Distinguished Scientist Lecture Series seminar will take place Tuesday, March 2, from 7:30-8:30pm ET.
Astrix Technology Group is hosting a webcast series on “The Digital Laboratory: What the Future Holds." VP of Science Loren Perelman will discuss scientific blueprints for this series on February 18.
In this JMP Statistically Speaking Webinar, Riffyn CEO Tim Gardner illustrates why science needs to shift from a binary hypothesis-driven approach to a multivariate model-driven experimental paradigm.
Industry accounts for approximately 30 percent of global greenhouse gas emissions. How can the US manufacturing sector increase its competitiveness while also addressing climate change issues?
Riffyn CEO Tim Gardner is on the speaker line up for TWB START-UP DAY 2021, a virtual event hosted by Toulouse White Biotechnology from February 2-3, 2021.
Riffyn CEO Tim Gardner will join a JMP-hosted panel discussion featuring analysts from many different fields who are maximizing data and their analytics expertise to make the world a better place.
Riffyn CEO, Tim Gardner, will present on October 7 in Pharmaceutical R&D Informatics at 11:30a and 12:00p EST. You can also visit us at our virtual booth.
Riffyn CEO Tim Gardner will join a panel of experts from Synthace, TeselaGen, and Calico Labs at SynBioBeta 2020 in a session entitled "Computer aided biology: next generation software and analytics."
Riffyn VP of Science, Loren Perelman, will present at 3:40p EST on 21 September on Riffyn Nexus: A Digital Backbone for Process Development & Tech Transfer.
Riffyn CEO, Tim Gardner, will present on "A digital backbone to accelerate process development, analytical methods, and transfer to manufacturing." — Also visit our booth.
Commercializing Industrial Biotechnology is a workshop where industrial biotech thought leaders share their experiences and their views on current challenges.
At this event in collaboration with Synbiobeta, we will bring together leaders in the field of synthetic biology to discuss how we can re-imagine R+D, digitalization, and manufacturing.
Riffyn CEO, Tim Gardner, joined an expert panel hosted by JMP on 23 June to discuss the profound impact of DoE on scientific discovery. Watch the recording.
Riffyn will be participating in the Bio-IT World webinar series on the 17th June 2020: Will COVID-19 Produce a New Normal in R&D -- Faster, More Decentralized, More Digitized?
Timothy Gardner will lead a breakout discussion on creating a digital backbone for biomanufacturing as part of the SynBioBeta Built with Biology Summit.
The number one asset of any R&D company is its data — if it's meaningful and trustworthy. Tim Gardner discusses creating and harnessing data with Riffyn Nexus & JMP. Watch recording here.